In this issue:
PET adapted approach for bulky, early-stage cHL patients
Complete/sustained BTKi to minimise off-target inhibition-related toxicities
Lenalidomide and ibrutinib for DLBCL patients
Efficacy and safety of chidamide in T-ALL patients
Racial and ethnic disparities in childhood ALL
Effect of trial participation on OS for HL
Efficacy and safety of intramuscular JZP458 in ALL
NGS detection of prognostic factors for de novo FLT3-ITD AML patients
Cost-effectiveness of mammography and breast MRI in female chest-irradiated childhood HL
Real-world duration of ibrutinib treatment
Please login below to download this issue (PDF)